Trinity College Dublin

Skip to main content.

Top Level TCD Links

Non peer reviewed publications

Click on the underlined column headings to reorder these publications and other research outputs.
Non Peer Reviewed Publications and Other Research Outputs. Total: 282
Type Reference Year Status
Journal Article 2NN Study Group includes Dr Fiona Mulcahy, Comparison of first-line antiretroviral therapy with regimens including Nevirapine, Efavirenz or both drugs, plus stavudine and lamivudine: a randomised open-label trail, the 2NN Study, The Lancet, 363, (9417) PUBLISHED
Report Dr Fiona Mulcahy – Principal Investigator for St James Hospital, Dublin, A randomised, open label. phase III, international study of subcutaneous recombinant IL-2 (Proleukin) in patients with HIV-1 infection and CD4 cell counts > 300/mm3: Evaluation of Subcutaneous Proleukin in a randomised international trial (ESPRIT) PUBLISHED
Report Dr Fiona Mulcahy – Principal Investigator for St James Hospital, Dublin, An open-label comparative study to evaluate the antiviral efficacy and safety of Nevirapine and Efavirenz or both drugs combined in combination with d4T and 3TC (2NN study) PUBLISHED
Report Dr Fiona Mulcahy – Principal Investigator for St James Hospital, Dublin, A phase IV randomised open-label trial to evaluate the safety and efficacy of continued 3TC twice-daily therapy versus discontinuation of 3TC, as part of the second-line treatment of HIV-1 infection in patients who have shown virological failure on first-line combination treatments containing 3TC (Colate) PUBLISHED
Report Dr Fiona Mulcahy – Principal Investigator for St James Hospital, Dublin, An open label pharmacokinetic study to evaluate the interaction between Nevirapine and Methadone in HIV-1 infected, opoid-dependent adults on stable methadone maintenance therapy. (Methadone/Neviripine study) PUBLISHED
Report Dr Fiona Mulcahy – Principal Investigator for St James Hospital, Dublin, A randomised open-label. comparative safety and efficacy study of tipranavir boosted with low dose ritonavir versus genotypically-defined protease inhibitor/ritonavir in multiple antiretroviral drug-experienced patients (Resist 2 1182.48) PUBLISHED
Report Dr Fiona Mulcahy – Principal Investigator for St James Hospital, Dublin, A long term open-label rollover trial assessing the safety and tolerability of combination tipranavir and ritonavir use in HIV-1 infected subjects. (Resist 1182.17) PUBLISHED
Working Paper Keane, Joseph, Diagnostic Standards & Classification of Tuberculosis in Adults and Children SUBMITTED
Working Paper Keane, Joseph, TNF blockade and opportunistic infection –A position paper SUBMITTED
Journal Article Bede P, The Role of Magnetic Resonance Imaging in Motor Neuron Disease , Connect, Journal of the IMNDA , October, (10), 2013, p9 - 10 2013 PUBLISHED
Book Chapter An overview of microRNA methods: expression profiling and target identification in, editor(s)Virginia Espina & Lance Liotta , Methods in Molecular Biology, Springer, 2012, pp119 - 138, [Smith SM, Murray DW.] 2012 PUBLISHED
Report Wyllie C, Platt S, Brownlie J, Chandler A, Connolly S et al, Men, suicide and society - why disadvantaged men in mid-life die by suicide, Samaritans, September, 2012 2012 PUBLISHED
Book Chapter Strategies for the purification of membrane proteins in, editor(s)Dermot Walls & Sinead Loughran , Methods in Molecular Biology, Springer, 2011, pp485 - 496, [Smith SM] 2011 PUBLISHED
Journal Article Nowostawska M., Corr S.A., Byrne S.J., Volkov Y., Gun'ko T.K. , Porphyrin-magnetite nanoconjugates for biological imaging, Journal of Nanobiotechnology, 9, (1), 2011, p1 2011 PUBLISHED
Journal Article Bede P, MRI study in MND, Connect, Journal of the IMNDA , October, (6), 2011, p9- 2011 PUBLISHED
Meeting Abstract Zhernakova, A., Stahl, E.A., Trynka, G., Raychaudhuri, S., Festen, E., Franke, L., Fehrmann, R.S.N., Kurreeman, F.A.S., Thomson, B., Gupta, N., Romanos, J., McManus, R., Ryan, A.W., Turner, G., Remmers, E.F., Greco, L., Toes, R., Grandone, E., Mazzilli, M.C., Rybak, A., Cukrowska, B., Li, Y., de Bakker, P.I.W., Gregersen, P.K., Worthington, J., Siminovitch, K.A., Klareskog, L., Huizinga, T.W.J., Wijmenga, C., Plenge, R.M., "Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci.", Annals of the Rheumatic Diseases, 70, 2011, ppA21 2011 PUBLISHED
Journal Article Davis, A., McElligott, A., Pidgeon, G., Ryan, A., Foley, R. , "Cancer biology where do we go next?", European Pharmaceutical Review, (1), 2010 2010 PUBLISHED
Meeting Abstract Ryan, A.W., Linehan, E., Turner, G., Gallagher, P., Irvine, A., Fitzgerald, O., Kirby, B., McManus, R. , "The copy number variant LCE3C_LCE3B-del on chromosome confers susceptibility to psoriasis in the Irish population", Ulster Medical Journal , 79, (1), 2010, pp33 - 42 2010 PUBLISHED
Journal Article Feighery CF, McManus R, Recent advances in the genetic understanding of coeliac disease, Proceedings of the Nutrition Society, 68, 2009, p1 - 5 2009 PUBLISHED
Meeting Abstract Ryan, A.W., Al-Jubury, K., Turner, G., Gallagher, P., Irvine, A., Fitzgerald, O., Kirby, B., McManus, R. , "IL18 and IL2 polymorphism in psoriasis susceptibility in the Irish population", Ulster Medical Journal, 78, (1), 2009, pp65 - 74 2009 PUBLISHED
Conference Paper Verma N.K., Davies A.M., Long A., Kelleher D., Volkov Y., Selective inhibition of Stat3 expression induces apoptosis in human cutaneous T-lymphoma cell line Hut78, EJC Supplements, 20th EORTC-NCI-AACR Symposium on molecular targets and cancer therapeutics, Geneva, Switzerland, 21-24 October, 6, (12), Pergamon-Elsevier Science LTD, 2008, pp118 2008 PUBLISHED
Conference Paper McCarthy J.E., Whelan D.M., Davies G.L., Byrne F., Conroy J., Volkov Y., Gun'ko Y., Fabrication and characterisation of photonic nanowires, Conference on Nanophotonic Materials, San Diego, CA, 10-12 August, edited by Gaburro Z, Cabrini S, Talapin D , 7030, SPIE-INT Soc Optical Engineering, 2008, pp3019 2008 PUBLISHED
Conference Paper Prina-Mello A., Byrne F., Coey J.M.D., Mohamed B.M., Davies A., Volkov Y., High content screening investigation of nanomaterial toxicological response to proliferating MC3T3-E1 osteoblast cells: a time course study. , Proceedings of the Scientific and Clinical Applications of Magnetic Carriers, Vancouver, Canada, May, edited by Hafeli, Schutt, Zborowski , 2008, pp49 2008 PUBLISHED
Conference Paper Whelan A.M., McCarthy J.E., Byrne F., Dowd F., Prina-Mello A., Coey J.M.D., Volkob Y., Gun'ko Y., Novel magnetic nanowires for cell labelling, 7th International conference on the Scientific and Clinical Applications of Magnetic Carriers, Vancouver, Canada, May, edited by Hafeli, Schutt, Zborowski , 2008, pp212 2008 PUBLISHED
Meeting Abstract Dempsey E., Long A., Kelleher D., Volkov Y., LFA-1 dependent gene regulation during T cell migration, Keystone Symposia, Colorado, USA, 2008 2008 PUBLISHED
Meeting Abstract Spiers J.P., Edwards C., Rietz A., Jan E., Mulcahy F., Hennessy M., Volkov Y., Davies A.M., Protease inhibitor-induced cardiotoxicity: direct effects on cell viability and intracellular calcium levels, Ninth International Congress on Drug Therapy in HIV Infection, Glasgow, 9-13 November, 2008 2008 PUBLISHED
Meeting Abstract Ryan, A.W., Hughes, D., Ryan, T., McManus, R., Stoneking, M. , "Natural selection and disease susceptibility at the coagulation F13B locus", Ulster Medical Journal, 77, (1), 2008, pp65 - 76 2008 PUBLISHED
Miscellaneous Hughes R, Black C, Kennedy NP. , Public Health Nutrition Intervention Management: Community Engagement and Analysis, 2008, - 2008 PUBLISHED
Miscellaneous Hughes R, Black C, Kennedy NP., Public Health Nutrition Intervention Management: Problem Analysis, 2008, - 2008 PUBLISHED
Miscellaneous Hughes R, Black C, Kennedy NP. , Public Health Nutrition Intervention Management: Stakeholder analysis and engagement., 2008, - 2008 PUBLISHED
Miscellaneous Hughes R, Black C, Kennedy NP., Public Health Nutrition Intervention Management: Determinant Analysis, 2008, - 2008 PUBLISHED
Miscellaneous Hughes R, Black C, Kennedy NP., Public Health Nutrition Intervention Management: Capacity Assessment., 2008, - 2008 PUBLISHED
Miscellaneous Hughes R, Black C, Kennedy NP., Public Health Nutrition Intervention Management: Mandates for Action., 2008, - 2008 PUBLISHED
Miscellaneous Hughes R, Black C, Kennedy NP., Public Health Nutrition Intervention Management: Intervention Research and Strategy options., 2008, - 2008 PUBLISHED
Miscellaneous Hughes R, Black C, Kennedy NP., Public Health Nutrition Intervention Management: Risk management and strategy prioritisation., 2008, - 2008 PUBLISHED
Miscellaneous Hughes R, Black C, Kennedy NP., Public Health Nutrition Intervention Management: Writing Action Statements., 2008, - 2008 PUBLISHED
Miscellaneous Hughes R, Black C, Kennedy NP., Public Health Nutrition Intervention Management: Logic modelling., 2008, - 2008 PUBLISHED
Miscellaneous Hughes R, Black C, Kennedy NP., Public Health Nutrition Intervention Management: Implementation and evaluation planning, 2008, - 2008 PUBLISHED
Miscellaneous Hughes R, Black C, Kennedy NP., Public Health Nutrition Intervention Management: Implementation and monitoring., 2008, - 2008 PUBLISHED
Miscellaneous Hughes R, Black C, Kennedy NP., Public Health Nutrition Intervention Management: Process evaluation., 2008, - 2008 PUBLISHED
Miscellaneous Hughes R, Black C, Kennedy NP., Public Health Nutrition Intervention Management: impact and Outcome Evaluation., 2008, - 2008 PUBLISHED
Miscellaneous Hughes R, Black C, Kennedy NP., Public Health Nutrition Intervention Management: Evaluating Capacity Gains., 2008, - 2008 PUBLISHED
Miscellaneous Hughes R, Black C, Kennedy NP., Public Health Nutrition Intervention Management: Economic Evaluation., 2008, - 2008 PUBLISHED
Miscellaneous Hughes R, Black C, Kennedy NP., Public Health Nutrition Intervention Management: Reflective Practice and Valorisation., 2008, - 2008 PUBLISHED
Miscellaneous Hughes R, Black C, Kennedy NP., Public Health Nutrition Intervention Management: Educators guide., 2008, - 2008 PUBLISHED
Working Paper Keane, Joseph, Tuberculosis Guidelines: National TB Advisory Committee, 2008 2008 PUBLISHED
Conference Paper Rakovich Y.P., Gun'ko Y., Gaponik N., Rogach A.L., Volkov Y., Donegan J.F., Highly emissive CdTe nanowires grown in a phosphate buffer solution: Flim imaging and spectroscopic studies, ICONO Conference, Minsk, Byelarus, May 28 - 1 June, edited by Aktsipetrov OA, Shalaev SV, Gaponenko SV, Zheludev NI , 6728, SPIE-INT Soc Optical Engineering, 2007, pp72805 2007 PUBLISHED
Conference Paper Zheng C.X., Long A., Volkov Y., Davies A., Kelleher D., Ahmad K., A cross-modal system for cell migration image annotation and retrieval, International Joint Conference on Neural Networks, Orlando, Florida, 12-17 August, Vols 1-6, 2007, pp1738 - 1743 2007 PUBLISHED
Meeting Abstract Ryan, A.W., Mattiangeli, V., Morris, D.W., Daly, J.S., Kelleher, D., McManus, R., "Allele frequency spectra in disease populations", Ulster Medical Journal, 76, (1), 2007, pp1 - 9 2007 PUBLISHED
Meeting Abstract Brophy, K., Ryan, A., O’Morain, C., Kennedy, N., McLoughlin, R., Stevens, F., Feighery, C., Kelleher, D., McManus, R., "Association of the IL18 gene with celiac disease in the Irish population", Ulster Medical Journal, 76, (1), 2007, pp1 - 9 2007 PUBLISHED
Meeting Abstract Petrovic D., Golden-Mason L., Mitchell S., Volkov Y., O'Farrelly C., Kelleher D., Long A., The envelope protein of the hepatitis C virus (E2) inhibits IL-2 secretion from T lymphocytes, Gastroenterology, Digestive Disease Weeking Meeting, Washington DC, May 19-24, 132, (4), WB Saunders Co-Elsevier, 2007, ppA735 - A735 2007 PUBLISHED
Meeting Abstract Williams Y., Sukhanova Y., Davies A., Nabiev I, Volkov Y., High content analysis of size-dependent nanoparticle distribution within human cell lines, ESF Research Conference probing interactions between Nanoparticles/ Biomaterials and Biological systems - Alternative approaches to Bio and Nano safety, Sant Feliu De Guixols, Spain, 3-8 November, 2007 2007 PUBLISHED
Meeting Abstract Prina-Mello A., Byrne F., Whelan A., Gounko I., Coey M., Volkov Y., Nanotoxicological study on nanocomposite materials on cell lines, Nanotechnology: implications for human health, the environment and food safety, Dublin, 2nd November, 2007 2007 PUBLISHED
Meeting Abstract Toetsch S., Volkov Y., Engineered biochips for study of trans-endothelial leukocyte migration, Institute of Molecular Medicine 10th Annual Conference, Dublin, 29-30 November, 2007 2007 PUBLISHED
Meeting Abstract Verma N.K., Davies A.M., Theng O.S., Long A., Kelleher D., Volkov Y., Stat3 involvement in LFA-1 mediated T-Cell migration, Keystone Symposium, Colorado, USA, 5-10 January, 2007 2007 PUBLISHED
Meeting Abstract Verma N.K., Volkov Y., A new microtubule targeting compound PBOX-15 inhibits T cell migration via post-translational modifications of tubulin, Journal of Molecular Medicine, Institute of Molecular Medicine 10th Annual Conference, Dublin, 29-30 November, 86, (4), 2007, pp457 - 469 2007 PUBLISHED
Meeting Abstract Williams Y., Volkov Y., The whys and wherefores of Nanotechnology in the development of cell biology and drug delivery, Health Research Board Research Communication Day, Dublin, November, 2007 2007 PUBLISHED
Meeting Abstract Toetsch S.,Shvets I., Volkov Y., New biochips for a 3-D study of transendothelial leukocyte migration, The 13th Society for Biomolecular Medicine (SBS) Annual Conference and Exhibition, Montreal, Canada, 15-19 April, 2007 2007 PUBLISHED
Meeting Abstract Olwell P., Kelleher D., Volkov Y., An investigation into the effects of the shape and velocity of white blood cells on the efficiency of the inflammatory response, LTH Research , Dublin, 31st October, 2007 2007 PUBLISHED
Meeting Abstract Dempsey E., Long A., Kelleher D., Volkov Y., LFA-1 dependent gene regulation during T cell migration, Institute of Molecular Medicine 10th Annual Conference, Dublin, 29-30 November, 2007 2007 PUBLISHED
Meeting Abstract Williams Y., Sukhanova A., Davies A., Nabiev I., Volkov Y., High content analysis of size-dependent nanoparticle distribution within human cell lines, Institute of Molecular Medicine Post Graduate Research Day, Dublin, 7th September, 2007 2007 PUBLISHED
Journal Article Tomkin GH. Lally SE, Owens D, Does fasting alter genes regulating cholesterol metabolism? A study of intestinal and hepatic Niemann Pick-C1-Like 1, ABCG5/G8, MTP and HMGCoA reductase, Atherosclerosis, 7, 2006, p39 - 39 2006 PUBLISHED
Journal Article Tomkin GH. Lally SE, Owens D, Sitosterol and cholesterol in chylomicrons of type 2 diabetic and non-diabetic subjects: the relationship to ATP binding cassette proteins G5 and G8 and Niemann Pick C1-like 1 mRNA, Atherosclerosis, 188, 2006, pS4 - S4 2006 PUBLISHED
Journal Article Tomkin GH, Lally SE, Owens D, Comparison of the effect of pioglitazone and insulin on postprandial lipoprotein composition and expression of genes affecting cholesterol absorption, synthesis and chylomicron assembly, Diabetologia, 2006 2006 PUBLISHED
Journal Article Tomkin GH, Lally SE, Owens D, Diabetic dyslipidaemia is associated with alteration in genes affecting cholesterol absorption, excretion and postprandial lipoprotein assembly. A study in streptozotosin diabetic, Diabetes, 2006 2006 PUBLISHED
Meeting Abstract Ryan, A.W., Mapp, J., Moyna, S., Mattiangeli, V., Kelleher, D., Bradley, D.G., McManus, R., "Heterogeneous levels of inter-population differentiation among different functional classes of immunologically important genes", Ulster Medical Journal, 75, (1), 2006, pp97 - 107 2006 PUBLISHED
Meeting Abstract Turner, G., Ryan, A.W., McManus, R., "The role of regulatory regions on chromosome 5q in genetic susceptibility to coeliac disease", Ulster Medical Journal, 75, (1), 2006, pp97 - 107 2006 PUBLISHED
Meeting Abstract Mohamed B.M., Feighery C., Kelleher D., Volkov Y., Davies A., Williams Y., Kelly J., Abuzakout M., Quantitative analysis of enterocyte structure of patients with positive coeliac disease serology and normal duodenal mucosa, Cellomics European User Group Meeting, Dublin, June, 2006 2006 PUBLISHED
Meeting Abstract Mohamed B.M., Feighery C., Kelleher D., Volkov Y., Davies A., Williams Y., Kelly J., Abuzakout M., Quantitative analysis of enterocyte structure of patients with positive coeliac disease serology and normal duodenal mucosa, The 12th International Symposium on coeliac disease, New York, USA, November, 2006 2006 PUBLISHED
Meeting Abstract Olwell P., Toetsch S., Long A., Kelleher D., Volkov Y., On the rebound: Chemorheotaxis and its role in the multistep paradigm, Institute of Molecular Medicine Research Day, Dublin, 18th October, 2006 2006 PUBLISHED
Invited Talk Kennedy MJ, Cancer Clinical Trials, Grasping the Initiative, Cancer 2005, St James’s Hospital, Dublin, April, 2005 2005 PRESENTED
Invited Talk Kennedy MJ, Hormonal therapy of Metastatic Breast Cancer, 5th All Ireland Breast Cancer Conference, Barberstown Castle, Dublin, October, 2005 2005 PRESENTED
Invited Talk Kennedy MJ, Sytstemic Therapy of Breast Cancer, Irish Society of Medical Oncology, Annual Practice Guidelines Meeting, Roganstown, Dublin, September, 2005 2005 PRESENTED
Journal Article Kelleher D, McManus R., Mechanisms of steroid action and resistance in inflammatory bowel disease , Falk Symposia, 2005 2005 PUBLISHED
Meeting Abstract Gun'ko Y.K., Byrne S., Mitchell S., Volkov Y, Preparation and biological investigation of luminescent water soluble CdTe nanoparticles, OPTO Ireland, Dublin, 4-6 April, 2005 2005 PUBLISHED
Meeting Abstract Rakovich Y.P, Volkov Y., Mitchell S., Kelleher D., Gaponik N., Donegan J.F., Rogach A.L., Highly emissive nanowires grown from CdTe nanocrystals in a phosphate buffer solution, OPTO Ireland, Dublin, 4-6 April, 2005 2005 PUBLISHED
Meeting Abstract Gun'ko Y.G., Mitchell S., Volkov Y., Rakovich Y., Investigation of photoetching processes in CdTe quantum dots, 29th Annual M.S.I Meeting, Focus Institute,, Dublin Institute of Technology, 2005 2005 PUBLISHED
Meetings /Conferences Organised Keane, Joseph, American Thoracic Society - Programme committee, In:American Thoracic Society Conference, 2005 2005 PRESENTED
Review A.M. Molloy, J.M. Scott., Nutrition and metabolism., Current Opinions in Lipidology , 16, (4), 2005, p494-496 2005 PUBLISHED
Conference Paper JJ Nolan, Current Perspectives in Paediatric Type 2 Diabetes, International Society for Paediatric and Adolescent Diabetes, Singapore, November 2004, edited by Merck Sante , 2004, pp1 - 8 2004 PUBLISHED
Conference Paper McManus, R., Brophy, K., Abuzakouk, M., Feighery, C., Kennedy, N.P., Stevens, F.M., Kelleher, D., Ryan, A.W. , "Chromosomal regions 2q33 and 5q31-q33 in genetic susceptibility to celiac disease in the Irish population", Proceedings of the 11th International Symposium on Coeliac Disease, Belfast, 28 – 30 April, 2004 2004 PUBLISHED
Invited Talk Kennedy MJ, Chemotherapy for Breast Cancer, Mater 8th Annual Breast Cancer Symposium, Mater Hospital, Dublin, May, 2004 2004 PRESENTED
Journal Article Kelleher D, Farrell R, McManus R, Pharmacogenetics of inflammatory bowel disease, in ‘Inflammatory bowel disease - crossroads between microbes, epithelium and immune systems’ , Novartis Foundation Symposium , 263, 2004 2004 PUBLISHED
Journal Article EuroSIDA study Group includes Dr Fiona Mulcahy, Changing Incidence of central nervous system diseases in EuroSIDA cohort, American Neurological Association, 2004 2004 PUBLISHED
Journal Article Results from the EuroSida Study Group. (includes Mulcahy F), Changes in hospital admission across Europe: 1995 – 2003, HIV Medicine, 5, 2004, p437 - 447 2004 PUBLISHED
Meeting Abstract Brophy K, Ryan A, Feighery C, O'Morain C, Kennedy N, McLoughlin R, Stevens F, Kelleher D, McManus R., "ICOS and CD28 gene polymorphisms and celiac disease", Gastroenterology, 126, (4), 2004, ppA247 Suppl 2 2004 PUBLISHED
Meeting Abstract DAD study (Includes Mulcahy F), Predictors of hypertension and changes in blood pressure in HIV infected patients, 11th Conference on Retroviruses and Opportunistic Infections, February, 2004 2004 PUBLISHED
Meeting Abstract E Devitt, S Hopkins, F Mulcahy, C Bergin, Rising number os HIV infection after a syphilis epidemic, 11th Conference on Retroviruses and Opportunistic Infections, February, 2004 2004 PUBLISHED
Meeting Abstract S Hopkins, A Khalid, G Courtney, F Mulcahy, C Bergin, Syphilis treatment outcomes in HIV infected and non-infected individuals, 11th Conference on Retroviruses and Opportunistic Infections, February, 2004 2004 PUBLISHED
Meeting Abstract DAD study. (Includes Mulcahy F) , Cardio and cerebrovascular events and predicted rates of mycocardial infarction, 11th Conference on Retroviruses and Opportunistic Infections, February, 2004 2004 PUBLISHED
Meeting Abstract M Hennessy, F Mulcahy, P Spiers, S Hospkins, P Hoggard, S Kewn, D Back, C Bergin, Differential effects of Combined Pegylated Interferon and Ribavirin Therapy? On intracellular Nucleotide Triphosphate levels in HIV/HCV coinfected patients: a potential mechanism for enhanced toxicity, 11th Conference on Retroviruses and Opportunistic Infections, February, 2004 2004 PUBLISHED
Meeting Abstract F. Lyons, S. Coughlan, C. Byrne, S. Hopkins, Wm. Hall, C. Bergin and F. Mulcahy, Emergence of genotypic resistance in HIV-1 infected pregnant women taking highly antiretroviral therapy to reduce mother-to-child transmission of HIV-1, Poster 892, 11th Conference on Retroviruses and Opportunistic Infections, San Francisco, February, 2004 2004 PUBLISHED
Meeting Abstract F.Lyons, E. Devitt, S. Hopkins, F. Mulcahy F, Sequential pregnancies in HIV infected women, BASHH/ASTDA Spring Meeting, Bath, UK, 19-21 May, 2004 2004 PUBLISHED
Meeting Abstract Mulcahy F, The effectiveness of partner notification for gonococcal infection: A comparison between men who have sex with men ( MSM) and heterosexual males, BASHH/ASTDA Spring Meeting, Bath UK, 19-21 May, 2004 2004 PUBLISHED
Meeting Abstract Mulcahy F, Co-infection with syphilis: natural history and management, 7th International Congress on Drug Therapy in HIV Infection, Glasgow, UK, 14-18 Nov, 2004 2004 PUBLISHED
Meeting Abstract Holmes A, McCullagh L, Bergin C, Mulcahy F, Long term follow up of a cohort of antiretroviral experienced HIV-1 infected pateitns simplified to Trizivir, 7th International Congress on Drug Therapy in HIV Infection, Glasgow, UK, 14-18 Nov, 2004 2004 PUBLISHED
Meeting Abstract Moriarty M, McCullagh L, Sabra K, Bergin C, Mulcahy F., A complete drug history should be sought, 7th International Congress on Drug Therapy in HIV Infection, Glasgow, UK, 14-18 Nov, 2004 2004 PUBLISHED
Meeting Abstract Chew N, Brannigan E, Lynch R, Mulcahy F, Bergin C., HIV tuberculosis coninfection. Changing prevalence and impact on antiretroviral use, 7th International Congress on Drug Therapy in HIV Infection, Glasgow, UK, 14-18 Nov, 2004 2004 PUBLISHED
Meeting Abstract Freeley M., Volkov Y, Kelleher D, Long A., Rapamycin-independent phosphorylation of PKCU at the C-terminal hydrophobic motif in T lymphocytes, Bio Science 2004 - From Molecules to organisms, Glasgow, 18-22 July, 2004 2004 PUBLISHED
Meetings /Conferences Organised Keane, Joseph, International Conference on Cytokine Medicine , 2004 - present, 2004 2004 PUBLISHED
Meetings /Conferences Organised Keane, Joseph, Institute of Molecular Medicine: Programme committee , 2004 - present, 2004 2004 PRESENTED
Journal Article McManus R, Kelleher D. , Celiac disease – the villain unmasked? , New England Journal of Medicine, 348, 2003, p2573 - 2574 2003 PUBLISHED
Journal Article McManus R, Mechanisms of Steroid Action and Resistance in Inflammation and Disease., Journal of Endocrinology, 178, (1), 2003, p1-4 2003 PUBLISHED
Meeting Abstract Daly, J., McManus, R., Hagan, R., Ryan, A., Ryan, B., Ang, Y., Farrell, R., Weir, D., Kelleher, D., "The TNF region in celiac disease", Gastroenterology , 124, (4), 2003, ppA658 2003 PUBLISHED
Meeting Abstract F. Lyons, S. Hopkins, A. Mc Geary, G. Sheehan, C. Bergin, and F. Mulcahy, Nevirapine tolerability in HIV infected women in pregnancy – A word of caution, Late breaker 27, 2nd IAS conference on HIV pathogenesis and treatment, Paris, France, July, 2003 2003 PUBLISHED
Meeting Abstract S Hopkins, H McDermott, F Lyons, C Bergin and F Mulcahy, Syphilis and the central nervous system (CNS) in HIV infected patients, 2nd IAS Conference on HIV pathogenesis and treatment, Paris, 2003 2003 PUBLISHED
Meeting Abstract F Lyons, S Hopkins, C Bergin and F Mulcahy, Maternal tolerability of antiretroviral therapy (art) in preventing vertical transmission (vt) of HIV-1, 9th European AIDS Conference, Warsaw, Poland, October, 2003 2003 PUBLISHED
Meeting Abstract S. Hopkins, F. Lyons, E. Brannigan, F. Mulcahy, C. Bergin, Pegylated Interferon and Ribavirin in HIV-HCV Coinfected Patients (Oral Presentation), British Infection Society, 6th Annual Scientific Meeting, London, 2003 2003 PUBLISHED
Meeting Abstract S. Hopkins, E. Brannigan, F. Lyons, H. McDermott, F. Mulcahy, C. Bergin, The Impact of treatment with Pegylated Interferon and Ribavirin on ART Prescribing in HIV-HCV Coinfected Patients. (Oral Presentation), Clinical Microbiology & Infection, 13th European Congress of Clinical Microbiology & Infectious Diseases, Glasgow, 9, (Supplement 1), 2003, pp52-O281 2003 PUBLISHED
Meeting Abstract S. Hopkins, L. Thornton, M. Fitzgerald, C. Merry, C. Bergin, F. Mulcahy, Case Finding Strategies in a Syphilis Outbreak, Clinical Microbiology & Infection, 13th European Congress of Clinical Microbiology & Infectious Diseases, Glasgow, 9, (Supplement 1), 2003, pp277 – P1171 2003 PUBLISHED
Meeting Abstract E. Brannigan, S. Hopkins, P. Coakley, F. Mulcahy, C. Bergin, Impact of Migration on the Prevalence of Mycobacterial Infections in HIV-postive Patients in Ireland, 13th European Congress of Clinical Microbiology & Infectious Diseases, Glasgow, 2003 2003 PUBLISHED
Meeting Abstract S. Hopkins, G. Farrell, F. Mulcahy. C. Bergin, HIV-HCV Coinfection : To Treat or Not to Treat, Antiviral Therapy, 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, Paris, 8, (Supplement 1), 2003, ppS458 - 459 2003 PUBLISHED
Meeting Abstract Wilson S., Volkov Y., Feighery C., Rearrangement of enterocyte cytoskeletal proteins in coeliac disease, Irish Society of Gastroenterology Winter Meeting, Dublin, 28-29 November, 2003 2003 PUBLISHED
Meeting Abstract MURPHY, N, P16INK4A, CDC6, MCM5 AND HPV STATUS: PREDICTIVE BIOMARKERS OF CERVICAL PRE-NEOPLASIA?, unknown, 2002, 198, ISI Web of Science, 2002, pp16A - 16A 2002 PUBLISHED
Meeting Abstract Prina-Mello A., Prendergast P.J., Volkov Y., Experimental analysis on two lymphatic cells under different topographical environments using a single cell motion method, Proceedings of the VIIIth Annual Conference of the section of Bioengineering of the Royal Academy of Medicine in Ireland, Ireland, 2002 2002 PUBLISHED
Meeting Abstract Volkov Y., Long A., McGrath S., Ni Eidhin D., Kelleher D., PKC beta 1 essential functional component in LFA-1 induced signalling and T cell locomotion, Proceedings of the International Conference "Cell adhesion in inflammation and cancer", Amsterdam, Holland, 2002 2002 PUBLISHED
Invited Talk Kennedy MJ, Strategies for the Management of Metastatic Breast Cancer, Second Annual Breast Cancer Theme Meeting, Four Seasons Hotel, Dublin, May 25th, 2001 2001 PRESENTED
Invited Talk Kennedy MJ, Why the Breast Cancer Epidemic?, Irish Association for Palliative Care Annual Meeting, Blackhall Place, Dublin, Nov 14th, 2001 2001 PRESENTED
Journal Article The Initio Co-Ordinating Committee, ( includes Mulcahy F), An open-label randomised trial to evaluate different therapeutic strategies of combination therapy in HIV-1 Infection: Design, Rationale and methods of the Initio trial, Controlled Clinical Trials, 22, (2), 2001 2001 PUBLISHED
Meeting Abstract CLARKE, SM, AN OUTBREAK OF SERIOUS UNEXPLAINED ILLNESS IN INJECTING DRUG USERS IN EUROPE - THE EXPERIENCE OF AN IRISH INSTITUTION, 2001, 33, ISI Web of Science, 2001, pp1119 - 1119 2001 PUBLISHED
Meeting Abstract CLARKE, S, ANALYSING LIMITING FACTORS IN THE ACCEPTANCE OF HAART IN INJECTION DRUG USERS (IDUS), 2000, 14, ISI Web of Science, 2001, ppS45 - S45 2001 PUBLISHED
Meeting Abstract MULCAHY, F, ANTIVIRAL THERAPY AND MANAGEMENT OF HIV IN INTRAVENOUS DRUG USERS, 2000, 14, ISI Web of Science, 2001, ppS2 - S2 2001 PUBLISHED
Meeting Abstract RYAN, M, CHANGING DEMOGRAPHICS OF AN IRISH HIV-INFECTED COHORT FROM 1995 TO 1999, 2000, 14, ISI Web of Science, 2001, ppS137 - S137 2001 PUBLISHED
Meeting Abstract COUGHLAN, S, CLINICAL UTILITY OF HIV-1 GENOTYPIC DRUG RESISTANCE TESTING IN A HETEROGENEOUS, NON-TRIAL POPULATION, 2000, 14, ISI Web of Science, 2001, ppS116 - S117 2001 PUBLISHED
Meeting Abstract MCMAHON, C, COCAINE-INDUCED THROMBOCYTOPENIA IN A YOUNG HIV SEROPOSITIVE INJECTING DRUG USER, 2000, 14, ISI Web of Science, 2001, ppS67 - S67 2001 PUBLISHED
Meeting Abstract RYAN, M, DETERMINING THE COST OF HOSPITALISATION OF HIV-INFECTED PATIENTS IN IRELAND IN ORDER TO ASSESS THE PHARMACOECONOMIC IMPACT OF HAART ON INPATIENT CARE, 2000, 14, ISI Web of Science, 2001, ppS101 - S101 2001 PUBLISHED
Meeting Abstract HARRINGTON, P, EFFICACY AND TOLERABILITY OF HYDROXYUREA CONTAINING SALVAGE ANTIRETROVIRAL REGIMENS IN THE MANAGEMENT OF HIV INFECTION, 2000, 14, ISI Web of Science, 2001, ppS35 - S35 2001 PUBLISHED
Meeting Abstract FAY, L, ERYTHRODYSETHESIA FOLLOWING DOXORUBICIN THERAPY FOR KAPOSI'S SARCOMA, 2000, 14, ISI Web of Science, 2001, ppS67 - S67 2001 PUBLISHED
Meeting Abstract HOPKINS, S, HEPATITIS C: PREVALENCE AND IMPLICATIONS FOR TREATMENT IN THE HIV CO-INFECTED POPULATION, 2000, 14, ISI Web of Science, 2001, ppS125 - S125 2001 PUBLISHED
Meeting Abstract MURPHY, N, IMMUNOCYTOCHEMICAL ANALYSIS OF P16 PROTEIN EXPRESSION IN CERVICAL CANCER AND CERVICAL INTRAEPITHELIAL NEOPLASIA., 2001, 195, ISI Web of Science, 2001, pp2A - 2A 2001 PUBLISHED
Meeting Abstract HENNESSY, M, INTRACELLULAR INDINAVIR PHARMACOKINETICS IN HIV POSITIVE PATIENTS, 2000, 14, ISI Web of Science, 2001, ppS97 - S97 2001 PUBLISHED
Meeting Abstract MCGRATH, E, LIFE-SAVING CHEMOTHERAPY FOR KAPOSI'S SARCOMA IN A HIV POSITIVE PREGNANT WOMAN, 2000, 14, ISI Web of Science, 2001, ppS131 - S131 2001 PUBLISHED
Meeting Abstract CURRAN, S, MYOCARDIAL INFARCTION AND PROTEASE INHIBITOR THERAPY: TWO CASE REPORTS, 2000, 14, ISI Web of Science, 2001, ppS62 - S62 2001 PUBLISHED
Meeting Abstract HENNESSY, M, ST JOHN'S WORT MODULATES BOTH EXPRESSION AND FUNCTION OF P GLYCOPROTEIN IN PERIPHERAL BLOOD LYMPHOCYTES, 2000, 14, ISI Web of Science, 2001, ppS95 - S95 2001 PUBLISHED
Meeting Abstract CLARKE, S, THE ACTIVE MANAGEMENT OF HIV IN PREGNANCY, 2000, 14, ISI Web of Science, 2001, ppS138 - S139 2001 PUBLISHED
Meeting Abstract CLARKE, S, THE PHARMACOKINETIC INTERACTION BETWEEN METHADONE AND NELFINAVIR, 2000, 14, ISI Web of Science, 2001, ppS95 - S95 2001 PUBLISHED
Meeting Abstract Freeley M., Volkov Y., Kelleher D., Long A., Investigation into the activation status of protein kinase C (PKC) isoforms Beta 1, delta and u in a jurkat T cell line using phosphor specific antibodies, British Biochemical Society Meeting, Dublin, 11-13 July, 2001 2001 PUBLISHED
Meeting Abstract Fanning A., Volkov Y., McGrath S., Kelleher D., Cross-linking of CD44 induces PKC-mediated signalling events in lymphocyte migration, 54, Scandinavian Journal of Immunology, 2001 2001 PUBLISHED
Meeting Abstract Volkov Y., Long A., McGrath S., Ni Eidhin D., Kelleher D., Crucial importance of PKC-(1) enzyme in LFA-1 mediated locomotion of activated T cell, Scandinavian Journal of Immunology, 54, 2001 2001 PUBLISHED
Meeting Abstract Spiers J.P., Hennessy M., Scott K., Volkov Y., Kavanagh P., Kelleher D., Feely J., Receptor-mediated internalisation of a fluorescein labelled endothelin-1 in a human endothelial cell line, British Journal of Pharmacology, 2001 2001 PUBLISHED
Meeting Abstract El Homasany B., Volkov Y., Long A., Takahashi M., Ono Y., Kelleher D., The novel scaffolding protein CG-NAP is a component of LFA-1 induced cytoskeleton signalling complex in locomotory T cells, Scandinavian Journal of Immunology, 2001 2001 PUBLISHED
Meeting Abstract Prina-Mello A., Prendergast P.J., Volkov Y., T lymphatic cells response to microtextured surface: difference between HUT78 and PBTL cells, Proceedings of the 5th International Conference in Cellular Engineering, St 17 Aachen, Germany, 4-7 July, 2001 2001 PUBLISHED
Meeting Abstract Prina-Mello A., Prendergast P.J., Volkov Y., Is there any difference between T cells HUT78 and peripheral blood lymphocyte cell (PBTL) during crawling locomotion?, Proceedings of the VIIth Annual Conference of the section of Bioengineering of the Royal Academy of Medicine in Ireland, 2001 2001 PUBLISHED
Meeting Abstract Moretti M., Prina-Mello A., Prendergast P.J., Volkov Y., Stimulation of cell crawling using FEA-based tensegrity model, Proceedings of the VIIth Annual Conference of the section of Bioengineering of the Royal Academy of Medicine in Ireland, 2001 2001 PUBLISHED
Review MILLER, V, LOVEDAY, C, STASZEWSKI, S, LUNDGREN, J, YOULE, M, AIT-KHALED, M, BOUCHER, C, BRUN-VEZINET, F, DEDES, N, GIAQUINTO, C, HERTOGS, K, HOUYEZ, F, PERRIN, L, PILLAY, D, SCHMIT, JC, SCHUURMAN, R, LANGE, J, BANHEGYI, D, BIONDI, G, BROEKHUIZEN, A, BUSH-DONOVAN, C, CAMACHO, R, CARLIER, H, CLAVEL, F, CLOTET, B, CLUMECK, N, COLEBUNDERS, R, DE CLERQ, K, DE JAEGHER, JJ, DE SCHRIJVER, G, DE SMET, K, HALL, W, HARRIGAN, R, HATZAKIS, A, HELLMANN, N, HOETELMANS, R, HOLTZER, C, KATLAMA, C, LARDER, D, LORIAUX, E, MCCREEDY, B, MULCAHY, F, OPRAVIL, M, PHILLIPS, A, RUIZ, N, SHULSE, E, SONNERBORG, A, SORIANO, V, STEEL, H, VELLA, S, WILLIAMS, A, CLINICAL AND LABORATORY GUIDELINES FOR THE USE OF HIV-1 DRUG RESISTANCE TESTING AS PART OF TREATMENT MANAGEMENT: RECOMMENDATIONS FOR THE EUROPEAN SETTING, by VANDAMME, AM , AIDS, 15, 2001 2001 PUBLISHED
Invited Talk Kennedy MJ, Approaching a Cure for Breast Cancer, Mater 4th Annual Breast Cancer Symposium, Freeman Auditorium, November, 2000 2000 PRESENTED
Meeting Abstract Volkov Y., Long A., McGrath S., Ni Eidhin D., Kelleher D., Crucial importance of PKC-(1) isoenzymes for LFA-1 mediated microtubule rearrangement and T cell locomotion, Proceedings of the Keystone Symposium on Molecular and Vellular Biology "Protein Kinase C; Structure, regulation and cellular function", 2000 2000 PUBLISHED
Miscellaneous BARRY, M, HYDROXYUREA-INDUCED NEUROTOXICITY IN HIV DISEASE, 1999, - 1999 PUBLISHED
Miscellaneous CLARKE, S, MERRY, C, MORAN, AM, MULCAHY, F, PNEUMOCOCCAL PNEUMONIA ASSOCIATED WITH PERIANAL HERPES SIMPLEX VIRUS TYPE 2 IN A HIV SEROPOSITIVE PATIENT, 1999, - 1999 PUBLISHED
Review BARRY, M, PHARMACOKINETICS AND POTENTIAL INTERACTIONS AMONGST ANTIRETROVIRAL AGENTS USED TO TREAT PATIENTS WITH HIV INFECTION, by MULCAHY, F , CLINICAL PHARMACOKINETICS, 36, 1999 1999 PUBLISHED
Invited Talk Kennedy MJ, Developments in the Systemic Therapy of Breast Cancer: Is it time to change the paradigm?, Mt. Sinai Center for Breast Health Quarterly Lecture Series, Cleveland, Ohio, January 8, 1998 1998 PRESENTED
Invited Talk Kennedy MJ, New Advances in the Treatment of Breast Cancer, Ellis Hospital, Albany, New York, January 19, 1998 1998 PRESENTED
Invited Talk Kennedy MJ, Hormonal Therapy in the Treatment of Breast Cancer, Dayton Oncology Society, International Speaker Series, Kettering Hospital, Dayton, Ohio, January 22, 1998 1998 PRESENTED
Invited Talk Kennedy MJ, Where are we going with the Hormonal Therapy of Breast Cancer, Mother Divine Hospital, WilkesBarre, PA, January 27, 1998 1998 PRESENTED
Invited Talk Kennedy MJ, Advances in the Treatment of Breast Cancer, University of Pittsburgh, Pittsburgh, Pennsylvania, February 19, 1998 1998 PRESENTED
Invited Talk Kennedy MJ, Current Advances in the Treatment of Breast Cancer, Hoag Cancer Center, Orange County, California, March 19, 1998 1998 PRESENTED
Invited Talk Kennedy MJ, Development in the Cytotoxic Treatment of Breast Cancer, Grand Rounds, Winthrop University Hospital, Mineola, New York, April 1, 1998 1998 PRESENTED
Invited Talk Kennedy MJ, Update in Breast Cancer Treatment, Harbor Hospital, Baltimore, Maryland, May 7, 1998 1998 PRESENTED
Invited Talk Kennedy MJ, Advances in the Treatment of Anthracycline resistant breast cancer, University of Wisconsin Hospital, Marshfield, Wisconsin, May 5, 1998 1998 PRESENTED
Invited Talk Kennedy MJ, Dose-Dense Sequential Chemotherapy followed by High-Dose Consolidation: A Phase I Study in Women with High-Risk Node-Positive Breast Cancer, American Society of Clinical Oncology 34th Annual Meeting, Los Angeles, California, May 16-20, 1998 1998 PRESENTED
Invited Talk Kennedy MJ, Advances in the Treatment of Breast Cancer, Mt. Sinai Hospital, New York, NY, May 22, 1998 1998 PRESENTED
Meeting Abstract MERRY, C, AN OVERDOSE OF POST EXPOSURE PROPHYLAXIS IN A PREGNANT WOMAN., 1998, 12, ISI Web of Science, 1998, ppS57 - S57 1998 PUBLISHED
Meeting Abstract CONDON, S, COMBINATION ANTIRETROVIRAL THERAPY (ART) IN PREGNANCY: INFANT OUTCOME, 1998, 12, ISI Web of Science, 1998, ppS94 - S94 1998 PUBLISHED
Meeting Abstract BACK, D, INTERACTIONS BETWEEN ANTIRETROVIRALS, 1998, 12, ISI Web of Science, 1998, ppS6 - S6 1998 PUBLISHED
Meeting Abstract BARRY, M, RITONAVIR INDUCED HYPERLIPIDAEMIA IN PATIENTS WITH HIV DISEASE, 1998, 12, ISI Web of Science, 1998, ppS52 - S52 1998 PUBLISHED
Meeting Abstract MC MAHON, C, SUCCESSFUL USE OF PROTEASE INHIBITORS IN HIV-INFECTED PATIENTS WITH HAEMOPHILIA, 1998, 101, ISI Web of Science, 1998, pp87 - 87 1998 PUBLISHED
Invited Talk Kennedy MJ, Advances in the Treatment of Breast Cancer, Grand Rounds, Dwight Eisenhower Army Medical Center, Ft. Gordon, Georgia, January 10, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, What is the future of Breast Cancer Chemotherapy, Hematology/Oncology Grand Rounds, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, January 23, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Advances in the Treatment of Breast Cancer, Hurley Medical Center, Flint, Michigan, February 11, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Taxotere-How I use it in Breast Cancer, Network for Oncology Communication & Research, Boca Raton, Florida, February 21, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Breast Cancer: Is Survival Improving, Southern Maryland Hospital Center, Clinton, Maryland, February 26, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Advances in Treatment of Breast Cancer, Lawrence Memorial, February 28, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Significant Advances in Cancer Treatment, The Medical Center of Central Massachusetts, Marlboro, Massachusetts, March 1, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Issues related to the inclusion of High Dose Chemotherapy in the Breast Cancer Guidelines, National Comprehensive Cancer Network, Fort Lauderdale, Florida, March 5, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, What is the future of Breast Cancer Chemotherapy, American Association for Cancer Research Special Conference on Basic and Clinical Aspects of Breast Cancer, Keystone, Colorado, March 7-12, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Developments in the Cytotoxic Treatment of Breast Cancer, University of Virginia Hematology /Oncology Grand Rounds, Charlottesville, VA, March 14, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Advances in the Treatment of Breast Cancer, Washington Adventist Hospital, Tacoma Park, Maryland, March 21, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Meet the Professor - Breast Cancer, Johns Hopkins Oncology Center’s 23th Annual Symposium--Diagnosis and Treatment of Neoplastic Disorders, Baltimore, Maryland, April 4, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Advances in the Cytotoxic Treatment of Breast Cancer, The Cleveland Clinic Cancer Center, Cleveland, Ohio, May 8-9, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Meet the Professor: Breast Cancer; High Dose Therapy, American Society of Clinical Oncology 33rd Annual Meeting, Denver, Colorado, May 18, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Developments in the Cytotoxic Treatment of Breast Cancer, Oncology Grand Rounds, State University of New York, Stony Brook, New York, May 28, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, What is the Future of Chemotherapy for Breast Cancer, Oncology Center Research Conference, Duke University Medical Center, Durham, North Carolinia, June 5, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Recent Advances in the Cytotoxic Treatment of Breast Cancer, The Johns Hopkins Medical & Surgical Association - Biennial Celebration, Baltimore, Maryland, June 6, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Advances in the Treatment of Breast Cancer, Fox Chase Cancer Center, Philadelphia, PA, June 10, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Advances in the Treatment of Breast Cancer, Cleveland Clinic Cancer Center, Cleveland, Ohio, June 14, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Duration of Anti-Estrogen Therapy, Symposium on Anti-Estrogen Therapy for Breast Cancer, Fareston Speaker Educator Meeting, Bermuda, June 26-29, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Advances in the Treatment of Breast Cancer, Oncology Grand Rounds, Memorial Regional Hospital, Hollywood, FL, July 1, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Breast Cancer Diagnosis, Chemotherapy and Adjuvant Therapy, St. Joseph Medical Center, Towson, MD, July 2, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Advances in the Treatment of Breast Cancer, Hematology-Oncology Grand Rounds, Ohio State University, Columbus, Ohio, July 16, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Treatment of Carcinoma Breast, Hematology Grand Rounds, The Johns Hopkins University, School of Medicine, Baltimore, Maryland, July 21, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Advances in the Treatment of Breast Cancer, Grand Rounds, Sylvester Comprehensive Cancer Center, University of Miami Hospital, Miami, Florida, September 5, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Advances in the Treatment of Breast Cancer, University of Illinois, Chicago, Illinois, September 11, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, What is the future of Breast Cancer Chemotherapy, Frontiers in Breast Cancer Research, Diagnosis & Therapy, Doubletree Hotel, Rockville, Maryland, September 19, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Current Approaches in Cancer Therapy, The University of Massachusetts Medical School Cancer Center, Department of Medicine, Boston, Massachusetts, September 26, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Advances in the Treatment of Refractory/Anthracycline-Resistant Breast Cancer, Naples Community Hospital, Naples, Florida, October 8, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Advances in the Treatment of Breast Cancer, North Arundel Hospital, Glen Burnie, Maryland, October 9, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Developments in the Cytotoxic Therapy of Breast Cancer, Grand Rounds at the Medical College of Virginia, Richmond, Virginia, October 14, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Advances in the Treatment of Breast Cancer, Richland Memorial Hospital, Columbia, South Carolina, October 16, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Taxotere/Doxorubicin Combination Regimens, RPR Taxotere Speakers Training Workshop, Marriott’s Desert Springs Resort & Spa, Palm Desert, California, October 26, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Bone Marrow and/or Peripheral Stem Cell Transplant, The Cancer Center of Thibodaux Regional, Thibodaux, Louisiana, October 30, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Advances in the Treatment of Breast Cancer, Fourteenth Allen Zieger Memorial Lecture Series, Novi, Michigan, October 31, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Developments in the Cytotoxic Treatment of Breast Cancer, Grand Rounds, Greenbaum Cancer Center, University of Maryland, Baltimore, Maryland, November 3, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Advances in the Treatment of Breast Cancer, Holmes Regional Medical Center, Melbourne, Florida, November 6, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Treatment of Metastatic Breast Cancer, Army Regional ACP Lecture, Walter Reed Army Medical Center, Washington, D.C., November 13, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Fareston: Clinical Efficacy in Metastatic Breast Cancer, Chemotherapy Foundation Symposium XV, New York, NY, November 12-14, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Advances in the Treatment of Breast Cancer, Washington Adventist Hospital, Bethesda, Maryland, November 21, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Developments in the Cytotoxic Treatment of Breast Cancer, Rex Cancer Center, Raleigh, North Carolina, December 2, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Advances in the Treatment of Breast Cancer, Tumor Board, St. Jude Medical Center, Fullerton, California, December 8, 1997 1997 PRESENTED
Invited Talk Kennedy MJ, Mobilization of Tumor Cells with Autologous Progenitor Cell Mobilization, Workshop: Blood Cell Transplant/Hematopoietic Growth Factors, Keystone Colorado, January 16, 1996 1996 PRESENTED
Invited Talk Kennedy MJ, Clinical Management of Locally Advanced Breast Cancer, Leland R. Cowan Cancer Symposium, LDS Hospital, Salt Lake City, Utah, January 20, 1996 1996 PRESENTED
Invited Talk Kennedy MJ, ABMT in Breast Cancer: 1996 Update, Multidisciplinary Clinical Conference, Johns Hopkins Oncology Center, Baltimore, Maryland, February 15, 1996 1996 PRESENTED
Invited Talk Kennedy MJ, Developments in the Cytotoxic Therapy of Breast Cancer, Oncology Grand Rounds, Walter Reed Army Medical Center, Washington, DC, February 16, 1996 1996 PRESENTED
Invited Talk Kennedy MJ, Developments in the Cytotoxic Therapy of Breast Cancer, Tumor Board, Arlington Hospital, Arlington, Virginia, February 29, 1996 1996 PRESENTED
Invited Talk Kennedy MJ, Meet the Professor - Breast Cancer, Johns Hopkins Oncology Center’s 22th Annual Symposium, Diagnosis and Treatment of Neoplastic Disorders, Baltimore, Maryland, March 28, 1996 1996 PRESENTED
Invited Talk Kennedy MJ, Autologous graft vs host disease as immune therapy after high-dose chemotherapy for metastatic breast cancer. Medium-term follow up and comparison with historical controls, American Society of Clinical Oncology 32st Annual Meeting, Philadelphia, Pennsylvania, May 18-21, 1996 1996 PRESENTED
Invited Talk Kennedy MJ, Breast Cancer: Updates from ASCO 1996, Oncology Grand Rounds, Johns Hopkins Oncology Center, Baltimore, Maryland, May 31, 1996 1996 PRESENTED
Invited Talk Kennedy MJ, Post-transplant Immunotherapy by Induction of Autologous GVHD, Eighth International Symposium on Autologous Marrow and Blood Transplant, Arlington, Texas, August 20, 1996 1996 PRESENTED
Invited Talk Kennedy MJ, Recent advances in the cytotoxic treatment of Breast Cancer, Grand Rounds, Portsmith Naval Hospital, Tidewater, Virginia, September 20, 1996 1996 PRESENTED
Invited Talk Kennedy MJ, Advances in the Treatment of Breast Cancer, Medivision, Houston, Texas, October 10, 1996 1996 PRESENTED
Invited Talk Kennedy MJ, Post Transplant Immunotherapy By Induction of Autologous GVHD, Georgetown University, October 16, 1996 1996 PRESENTED
Invited Talk Kennedy MJ, What Every Woman and Her Family Should Know About Breast Cancer, Johns Hopkins - Green Spring Station, Lutherville, Maryland, October 22, 1996 1996 PRESENTED
Invited Talk Kennedy MJ, Taxotere in Anthracycline Resistant Breast Cancer, Saint Barnabas Cancer Center, Livingston, New Jersey, October 30, 1996 1996 PRESENTED
Invited Talk Kennedy MJ, Recent advances in the Treatment of Breast Cancer, Arlington Hospital, Arlington, Virginia, October 31, 1996 1996 PRESENTED
Invited Talk Kennedy MJ, Duration of Antiestrogen Therapy, Fareston Investigators Meeting, Palm Springs, California, November 2, 1996 1996 PRESENTED
Invited Talk Kennedy MJ, What is the Future of High Dose Chemotherapy for Breast Cancer, Vanderbilt University Cancer Center, Nashville, Tennessee, November 7-8, 1996 1996 PRESENTED
Invited Talk Kennedy MJ, Advances in the Treatment of Breast Cancer, Temple University Cancer Center, Philadelphia, Pennsylvania, November 12, 1996 1996 PRESENTED
Invited Talk Kennedy MJ, Development in the Cytotoxic treatment of Breast Cancer, St. Mary’s Hospital Tumor Conference, Richmond, Virginia, November 19, 1996 1996 PRESENTED
Invited Talk Kennedy MJ, The Clinical and Economic Rationale for Peripheral Blood Progenitor Cell Transplantation, American Society of Health-System Pharmacists, New Orleans, December 9, 1996 1996 PRESENTED
Invited Talk Kennedy MJ, Developments in the cytotoxic therapy of breast cancer, George Washington University Hospital, Washington, DC, February 10, 1995 1995 PRESENTED
Invited Talk Kennedy MJ, Current treatment of breast cancer, Second Annual Current Trends in Cancer Care Symposium, Lehigh Valley Hospital, Allentown, Pennsylvania, February 11, 1995 1995 PRESENTED
Invited Talk Kennedy MJ, High-dose chemotherapy for metastatic breast cancer, Harris Hospital, Fort Worth, Texas, March 23-24, 1995 1995 PRESENTED
Invited Talk Kennedy MJ, Autologous graft versus host disease, Oncology Grand Rounds, Georgetown University Lombardi Cancer Center, Washington, DC, March 28, 1995 1995 PRESENTED
Invited Talk Kennedy MJ, Autologous graft versus host disease, 7th Annual Bone Marrow and Stem Cell Transplantation Symposium, Montefiore Hospital, New York, New York, March 31, 1995 1995 PRESENTED
Invited Talk Kennedy MJ, The evolving role of Taxol in the treatment of solid tumors, Langhorn, Pennsylvania, May 2, 1995 1995 PRESENTED
Invited Talk Kennedy MJ, Improving the efficacy of therapy: Autologous graft versus host disease, Future Directions in Stem Cell Transplantation, Northern New Jersey Cancer Center at Hackensack Medical Center, New Jersey, May 12, 1995 1995 PRESENTED
Invited Talk Kennedy MJ, Autologous graft versus host disease for breast cancer, ahnemann University Hospital, Pennsylvania, May 15, 1995 1995 PRESENTED
Invited Talk Kennedy MJ, Peripheral blood progenitor cell infusions do not inhibit the induction of autologous graft-vs-host disease by a following high-dose chemotherapy, American Society of Clinical Oncology 31st Annual Meeting, Los Angeles, California, May 20-23, 1995 1995 PRESENTED
Invited Talk Kennedy MJ, Developments in the cytotoxic therapy of breast cancer, Oncology Grand Rounds, The Chester County Hospital, University of Pennsylvania, June 21, 1995 1995 PRESENTED
Invited Talk Kennedy MJ, Developments in the cytotoxic therapy of breast cancer, Chester County Hospital, Pennsylvania, June 21, 1995 1995 PRESENTED
Invited Talk Kennedy MJ, Bone marrow transplantation in breast cancer, Hoag Cancer Center, Newport Beach, California, October 5, 1995 1995 PRESENTED
Invited Talk Kennedy MJ, Developments in the cytotoxic therapy of breast cancer, Fifth Annual Solid Tumor Symposium, New York Medical College, Valhalla, New York, October 18, 1995 1995 PRESENTED
Invited Talk Kennedy MJ, Autologous Graft Versus Host Disease, Medical Oncology Grand Rounds, Long Island Jewish Cancer Center, Long Island, New York, October 26, 1995 1995 PRESENTED
Invited Talk Kennedy MJ, Autologous Graft Versus Host Disease, Hematology Conference, North Shore University Hospital, Manhasset, New York, October 26, 1995 1995 PRESENTED
Invited Talk Kennedy MJ, Developments in the cytotoxic therapy of breast cancer, Einstein Hospital, Philadelphia, Pennsylvania, November 10, 1995 1995 PRESENTED
Invited Talk Kennedy MJ, Developments in the Cytotoxic Therapy of Breast Cancer, Norristown Regional Cancer Center, Norristown, Pennsylvania, November 27, 1995 1995 PRESENTED
Invited Talk Kennedy MJ, Transplant and High Dose Chemotherapy in Breast Cancer, Meet the Professor Symposium - Advances in High Dose Chemotherapy and Autologous Bone Marrow Transplantation, Medical Society of Southern NY, Westchester Academy of Medicine, , November 29, 1995 1995 PRESENTED
Invited Talk Kennedy MJ, High Dose Chemotherapy of Breast Cancer, San Antonio, Texas, December 12, 1995 1995 PRESENTED
Invited Talk Kennedy MJ, The Induction of Autologous Graft-Versus-Host Disease in Breast Cancer, Clinical Updates and Controversies in the Management of Breast Cancer, Columbia University, New York, New York, December 15, 1995 1995 PRESENTED
Invited Talk Kennedy MJ, High Dose Chemotherapy of Breast Cancer - Is the Question Answered?, Houston, Texas, December 19, 1995 1995 PRESENTED
Journal Article Kennedy MJ, High-dose chemotherapy: Drug administration errors, Arm-In-Arm News, V, (8), 1995 1995 PUBLISHED
Journal Article Kennedy MJ, High-dose chemotherapy: Drug administration errors, Arm-In-Arm News, V, (8), 1995 1995 PUBLISHED
Invited Talk Kennedy MJ, New approaches to cancer chemotherapy, Milford Memorial Hospital, Delaware, March 12, 1994 1994 PRESENTED
Invited Talk Kennedy MJ, High dose chemotherapy for breast cancer, Oncology Symposium, Holy Cross Hospital, Silver Spring, Maryland, March 25, 1994 1994 PRESENTED
Invited Talk Kennedy MJ, Recent advances in the diagnosis and treatment of breast cancer, Howard County General Hospital, Columbia, Maryland, April 5, 1994 1994 PRESENTED
Invited Talk Kennedy MJ, Developments in cytotoxic therapy of breast cancer, Johns Hopkins Oncology Center’s 20th Annual Symposium--Diagnosis and Treatment of Neoplastic Disorders, Baltimore, Maryland, April 7-8, 1994 1994 PRESENTED
Invited Talk Kennedy MJ, Taxol--Current status and future trends, Spohn Health System Second Annual Oncology Conference, Corpus Christi, Texas, April 23-24, 1994 1994 PRESENTED
Invited Talk Kennedy MJ, Autologous graft versus host disease in the treatment of breast cancer, Oncology Grand Rounds, Massachussets General Hospital, Boston, Massachusetts, May 3, 1994 1994 PRESENTED
Invited Talk Kennedy MJ, Dose-finding study of paclitaxel and cyclophosphamide in patients with advanced breast cancer, 8th International Congress on Senology, Rio de Janeiro, Brazil, May 9, 1994 1994 PRESENTED
Invited Talk Kennedy MJ, The hematologic toxicity of the taxol/cytoxan doublet is sequence -dependent, American Society of Clinical Oncology 30th Annual Meeting, Dallas, Texas, May 14-17, 1994 1994 PRESENTED
Invited Talk Kennedy MJ, Single high flow apheresis for stem cell collection, Workshop on definition of CD34+ cell harvests predicting for rapid hematopoietic reconstitution, Chicago, Illinois, August 26, 1994 1994 PRESENTED
Invited Talk Kennedy MJ, Recent advances in the systemic treatment of breast cancer, 1994 Ralph R. Coffey Surgical Symposium, University of Missouri- Kansas City School of Medicine, Kansas City, Missouri, September 17, 1994 1994 PRESENTED
Invited Talk Kennedy MJ, High dose chemotherapy for metastatic breast cancer, Tumor Board Conference, Washington Hospital Center, Washington, DC, October 28, 1994 1994 PRESENTED
Invited Talk Kennedy MJ, High dose chemotherapy for breast cancer, Point Counterpoint, ACP Army Regional Meeting, Reston, Virginia, October 29, 1994 1994 PRESENTED
Invited Talk Kennedy MJ, High-dose chemotherapy treatment of breast cancer, Grand Rounds, Harrisburg, Pennsylvania, May 25, 1993 1993 PRESENTED
Invited Talk Kennedy MJ, Can breast cancer be cured by high-dose chemotherapy?, St. James’s Hospital, Dublin, Ireland, September 10, 1993 1993 PRESENTED
Invited Talk Kennedy MJ, The evolving role of taxol in the treatment of solid tumors, Advances in Oncology and Hematology Lecture Series, Chester County Hospital, Pennsylvania, September 15, 1993 1993 PRESENTED
Invited Talk Kennedy MJ, The evolving role of taxol in the treatment of solid tumors, University of Pennsylvania, September 15, 1993 1993 PRESENTED
Invited Talk Kennedy MJ, Adjuvant treatment of breast cancer, Grand Rounds, City Hospital, Martinsburg, West Virginia, October 1, 1993 1993 PRESENTED
Invited Talk Kennedy MJ, Dose intense therapy in the treatment of breast cancer, Memphis Oncology Journal Club Program, Memphis, Tennessee, November 18, 1993 1993 PRESENTED
Invited Talk Kennedy MJ, The evolving role of Taxol in the treatment of solid tumors, Tumor Board, St. Mary’s Hospital, Richmond, Virginia, December 7, 1993 1993 PRESENTED
Meeting Abstract Ryan, A.W., Duke, E.J. and Fairley, J.S., "The mitochondrial DNA of Irish house mice", Genetical Research, Cambridge, 61, 1993, pp148 1993 PUBLISHED
Invited Talk Kennedy MJ, Autologous graft versus host disease, MD Anderson Cancer Center, Houston, Texas, March 27, 1992 1992 PRESENTED
Invited Talk Kennedy MJ, Advances in the treatment of metastatic breast cancer with high dose chemotherapy, Johns Hopkins Oncology Center’s 18th Annual Symposium--Diagnosis and Treatment of Neoplastic Disorders, Baltimore, Maryland, April 3, 1992 1992 PRESENTED
Invited Talk Kennedy MJ, High dose chemotherapy for breast cancer, Grand Rounds, Christiana Hospital, Delaware, June 11, 1992 1992 PRESENTED
Invited Talk Kennedy MJ, Autologous bone marrow transplantation, European Society for Medical Oncology, Educational Conference, Lisbon, Portugal, October 23, 1992 1992 PRESENTED
Invited Talk Kennedy MJ, Chemotherapy of breast cancer, Grand Rounds, Andrews Airforce Base Medical Center, Washington DC, November 13, 1992 1992 PRESENTED
Invited Talk Kennedy MJ, Phase I study of novobiocin with high dose chemotherapy for metastatic breast cancer, 15th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, December 9, 1992 1992 PRESENTED
Review Kennedy MJ, Regulatory Mechanisms in Breast Cancer: Advances in Cellular and Molecular Biology of Breast Cancer, Journal Cancer Inst, 84, 1992, p531-532 1992 PRESENTED
Conference Paper Kennedy MJ, Marrow contamination, Forum on Emerging Treatments for Breast Cancer, 1991, pp87 - 100 1991 PRESENTED
Invited Talk Kennedy MJ, High dose chemotherapy for breast cancer, Grand Rounds, St. Agnes Hospital, Baltimore, Maryland, January 30, 1991 1991 PRESENTED
Proceedings of a Conference Kennedy MJ(ed.), Marrow contamination, Forum on Emerging Treatments for Breast Cancer. Proceedings, 1991, 87-100 p 1991 PUBLISHED
Invited Talk Kennedy MJ, High dose chemotherapy and autologous bone marrow rescue in breast cancer, Hopkins Oncology Center’s 15th Annual Symposium--Diagnosis and Treatment of Neoplastic Disorders, Baltimore, Maryland, April 7, 1989 1989 PRESENTED

Last updated 7 May 2009 Clinical Medicine (Email).